- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 31st, 2006
Ahmedabad-based pharma major Dishman Pharmaceuticals and Chemicals (DPCL) is keen to acquire biotech and nanotechnology contract research organisation (CRO) companies in the US and Europe.
Talking to Business Standard, J R Vyas, MD of Dishman Pharma, said, "We are keen to acquire CROs companies operating in biotech and nanotechnolgy research."
|Related News Press|
Artificial synapse rivals biological ones in energy consumption June 21st, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016
Radiation-guided nanoparticles zero in on metastatic cancer July 1st, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016